238 related articles for article (PubMed ID: 8421523)
1. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
Carter NS; Fairlamb AH
Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
Scott AG; Tait A; Turner CM
Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
[TBL] [Abstract][Full Text] [Related]
3. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
Suswam EA; Taylor DW; Ross CA; Martin RJ
Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
[TBL] [Abstract][Full Text] [Related]
4. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei.
Carter NS; Berger BJ; Fairlamb AH
J Biol Chem; 1995 Nov; 270(47):28153-7. PubMed ID: 7499305
[TBL] [Abstract][Full Text] [Related]
5. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited.
Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P
Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP
Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis and uptake of thiamine (vitamin B1) in bloodstream form Trypanosoma brucei brucei and interference of the vitamin with melarsen oxide activity.
Stoffel SA; Rodenko B; Schweingruber AM; Mäser P; de Koning HP; Schweingruber ME
Int J Parasitol; 2006 Feb; 36(2):229-36. PubMed ID: 16375907
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.
Fairlamb AH; Carter NS; Cunningham M; Smith K
Mol Biochem Parasitol; 1992 Jul; 53(1-2):213-22. PubMed ID: 1501641
[TBL] [Abstract][Full Text] [Related]
9. Changes in adenosine transport associated with melaminophenyl arsenical (Mel CY) resistance in Trypanosoma evansi: down-regulation and affinity changes of the P2 transporter.
Suswam EA; Ross CA; Martin RJ
Parasitology; 2003 Dec; 127(Pt 6):543-9. PubMed ID: 14700190
[TBL] [Abstract][Full Text] [Related]
10. Effects of intermediates of methionine metabolism and nucleoside analogs on S-adenosylmethionine transport by Trypanosoma brucei brucei and a drug-resistant Trypanosoma brucei rhodesiense.
Goldberg B; Rattendi D; Lloyd D; Sufrin JR; Bacchi CJ
Biochem Pharmacol; 1998 Jul; 56(1):95-103. PubMed ID: 9698093
[TBL] [Abstract][Full Text] [Related]
11. A nucleoside transporter from Trypanosoma brucei involved in drug resistance.
Mäser P; Sütterlin C; Kralli A; Kaminsky R
Science; 1999 Jul; 285(5425):242-4. PubMed ID: 10398598
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
Maina N; Maina KJ; Mäser P; Brun R
Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
[TBL] [Abstract][Full Text] [Related]
13. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
[TBL] [Abstract][Full Text] [Related]
14. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity.
Barrett MP; Zhang ZQ; Denise H; Giroud C; Baltz T
Mol Biochem Parasitol; 1995 Jul; 73(1-2):223-9. PubMed ID: 8577330
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs.
Munday JC; Eze AA; Baker N; Glover L; Clucas C; Aguinaga Andrés D; Natto MJ; Teka IA; McDonald J; Lee RS; Graf FE; Ludin P; Burchmore RJ; Turner CM; Tait A; MacLeod A; Mäser P; Barrett MP; Horn D; De Koning HP
J Antimicrob Chemother; 2014 Mar; 69(3):651-63. PubMed ID: 24235095
[TBL] [Abstract][Full Text] [Related]
16. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance.
Lanteri CA; Stewart ML; Brock JM; Alibu VP; Meshnick SR; Tidwell RR; Barrett MP
Mol Pharmacol; 2006 Nov; 70(5):1585-92. PubMed ID: 16912218
[TBL] [Abstract][Full Text] [Related]
17. The melaminophenyl arsenicals melarsoprol and melarsen oxide interfere with thiamine metabolism in the fission yeast Schizosaccharomyces pombe.
Schweingruber ME
Antimicrob Agents Chemother; 2004 Sep; 48(9):3268-71. PubMed ID: 15328083
[TBL] [Abstract][Full Text] [Related]
18. Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test.
Stewart ML; Krishna S; Burchmore RJ; Brun R; de Koning HP; Boykin DW; Tidwell RR; Hall JE; Barrett MP
Lancet; 2005 Aug 6-12; 366(9484):486-7. PubMed ID: 16084257
[TBL] [Abstract][Full Text] [Related]
19. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals.
De Koning HP
Mol Pharmacol; 2001 Mar; 59(3):586-92. PubMed ID: 11179454
[TBL] [Abstract][Full Text] [Related]
20. Molecular interactions underlying the unusually high adenosine affinity of a novel Trypanosoma brucei nucleoside transporter.
Al-Salabi MI; Wallace LJ; Lüscher A; Mäser P; Candlish D; Rodenko B; Gould MK; Jabeen I; Ajith SN; de Koning HP
Mol Pharmacol; 2007 Mar; 71(3):921-9. PubMed ID: 17185380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
